Back to top

BMO Capital Sticks to Their Buy Rating for Amgen (AMGN)

In a report released today, Evan Seigerman from BMO Capital maintained a Buy rating on Amgen, with a price target of $400.00. According to TipRanks...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Affiliated Managers Group, Inc. (AMG)

Amgen Inc. (AMGN)